Vivic Corp
Change company Symbol lookup
Select an option...
VIVC Vivic Corp
BAC Bank of America Corp
CMSQF Computershare Ltd
UNH UnitedHealth Group Inc
RYAAY Ryanair Holdings PLC
FNGO MicroSectors? FANG+? Index 2X Leveraged ETN
LAD Lithia Motors Inc
SBUX Starbucks Corp
HYLN Hyliion Holdings Corp
NIO NIO Inc
Go

Company profile

Vivic Corp. is a start-up company. The Company operates as a travel agency that organizes individual and group tours in the Dominican Republic, such as cultural, recreational, sport, business, ecotours and other travel tours. The products and services provided by the Company will include custom packages according to the client’s specifications. The Company plan to develop and offer its own tours in the Dominican Republic as well as third-party suppliers. The Company has not generated any revenue.

Closing Price
$2.53
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.53
Day's Low
2.53
Volume
110

Injectable Drug Delivery Market Worth USD 1,251.28 Billion and 12.9% CAGR; Rising Cases of COVID-19 Pandemic to Promote Growth, says Fortune Business Insights(TM)

12:43 pm ET August 24, 2020 (Globe Newswire) Print

The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by the end of 2027 owing to the increasing prevalence of various diseases and the need for easy drug delivery to various target sites. Injectable drug delivery helps to provide effective drug delivery experience with speedy delivery. It is also considered as one of the most efficient routes of administration, thus ensuring improved patient experience.

As per a report by Fortune Business Insights, titled, "Injectable Drug Delivery Market Size, Share & Industry Analysis, By Device Type (Conventional Injectable, Pre-filled syringes, Auto- injectors, Pen Injectors, and Wearable), By Product Type (Freeze-dried Products, Injectable Sterile Products), By End User (Hospitals, Homecare Settings, Clinics, and Others), and Regional Forecast, 2020-2027," the value of this market was USD 483.45 billion in the year 2019 and the forecast period is set between 2020 and 2027.

Major Industry Developments of the Injectable Drug Delivery Market include:

November 2017 - A new drug delivery system called the SMARTDOSE was introduced by West Pharmaceutical Services Inc. for treating patients with heart issues.

July 2019 - A new auto-injector drug for Humira was launched by Eisai Co. Ltd. and AbbVie to treat autoimmune diseases.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/injectable-drug-delivery-market-101044

The Report is based on the following Questions:

-- What is the nature of the market?

-- Which is the leading segment of this market and why?

-- Who are the major players of this market?

-- What are the key industry developments in this market?

Drivers & Restraints-

Rising Awareness about Minimal Invasive Treatment Mode to Add Impetus

The rising geriatric population and their vulnerability to various diseases stand as key factors boosting the global injectable drug delivery market growth. This, coupled with the rising prevalence of chronic diseases such as cancer, diabetes, heart disorders, and others will also add impetus to the market. Moreover, clinical studies and the adoption of innovative products for drug delivery are expected to boost the market growth. The current COVID-19 pandemic that has propelled the intensity of casualty cases in medical centers all over the world is also aiding in the expansion of the market.

On the contrary, factors such as high cost of the devices and the lack of adequate reimbursement policies may hamper the market growth in the coming years. Nevertheless, the increasing adoption of minimally invasive treatment methods and their ascending success rate are expected to create lucrative growth opportunities for the market in the coming years.

The current COVID-19 pandemic has left us in a world of outcry and devastation. The healthcare sector is overburdened with more number of patients than the number of beds available. Most businesses are at a temporary halt while some others are going an extra mile to generate enough revenue so as to make the midnight oil burn. The coronavirus pandemic has affected the world economy at large and we are all hoping for a remedy - an antidote to fight this disease will soon be invented so that we can go back to our normal life.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/injectable-drug-delivery-market-101044

Regional Analysis-

North America Covered Dominant Share Accountable to Increasing Construction Activities

North America accounted for the largest injectable drug delivery market share in 2019 with a revenue of USD 172.67 billion. This is accountable to the increasing adoption of innovative injectable medical products by patients suffering from chronic diseases such as cancer, diabetes, and other autoimmune disorders. This, coupled with the presence of major companies having their base in the developed nations of this region will also aid in the expansion of the regional market.

On the other side, the market in Asia Pacific is likely to rise with the fastest CAGR during the forecast period on account of the increasing prevalence of chronic diseases requiring medical aid on a regular basis, increasing awareness about drug delivery systems, and the rising inclination towards ready-to-use injectable from the conventional injectable.

Quick Buy - Injectable Drug Delivery Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101044

Competitive Landscape-

Companies Focusing on Novel Product Development for Better Revenue Generation

The competitive nature of the market for injectable drug delivery is consolidated in nature with a handful of players covering significant shares. These include companies such as SHL Medical AG, BD, and Insulet Corporation. However, the entry of more players in the coming years will result in the fragmented nature of the market.

The major objective of the players is to engage in research and development of novel advanced injectable drug delivery products such as wearable, bluetooth equipped devices, and others to maintain their position. On the other hand, they are looking forward to intensify the overall competition.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/injectable-drug-delivery-market-101044

Some of the Key Players of the Injectable Drug Delivery Market include:

-- Gerresheimer AG (Germany, Europe)

-- BD (New Jersey, U.S)

-- Insulet Corporation (Massachusetts, U.S)

-- Ypsomed AG (Switzerland, Europe)

-- SHL Medical AG (Switzerland, Europe)

-- Eli Lilly and Company (Indiana, U.S)

-- West Pharmaceutical Services, Inc. (Pennsylvania, U.S)

-- Elcam Medical (Israel, Middle East)

-- Pfizer Inc. (New York, U.S)

-- Others

Injectable Drug Delivery Market Segmentation:

By Device Type

? Conventional Injectable

? Pre-filled Syringes

? Auto-injectors

? Pen-injectors

? Wearable

By Product Type

? Freeze-dried Products

? Injectable Sterile Products

By End User

? Hospitals

? Home Care Settings

? Clinics

? Others

By Geography

? North America (the USA, and Canada)

? Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

? Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

? Latin America (Brazil, Mexico and the Rest of the Latin America)

? Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/injectable-drug-delivery-market-101044

Have a Look at Related Reports:

Drug Delivery Market Share & Industry Analysis, By Route of Administration (Injectable, Nasal, Topical & Transdermal, Oral and Others), By Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2019-2026

Nasal Drug Delivery Market Share and Industry Analysis, By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026

Connected Drug Delivery Devices Market Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/injectable-drug-delivery-market-9202

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.